From the Divisions of Neuroradiology.
Oncologic and Molecular Imaging, Department of Radiology, UMass Chan Medical School, Worcester, MA.
Clin Nucl Med. 2024 Sep 1;49(9):882-883. doi: 10.1097/RLU.0000000000005373. Epub 2024 Jul 5.
Prostate-specific membrane antigen (PSMA) PET/CT has become an unparalleled modality in the diagnosis of primary and recurrent prostatic adenocarcinoma, often revealing sites of disease that were previously invisible on conventional imaging. In this 78-year-old man with suspected prostate cancer recurrence, PSMA PET/CT revealed focal radiotracer uptake in the brain, which would ordinarily raise suspicion for metastases, but was a false positive in the setting of a recent stroke. Increased PSMA uptake has been reported in subacute infarcts and primary and secondary brain tumors. Careful history and comparison with prior imaging are vital to avoid false-positive diagnosis in such patients.
前列腺特异性膜抗原 (PSMA) PET/CT 已成为诊断原发性和复发性前列腺腺癌的一种无与伦比的方式,它经常能发现传统影像学检查无法显示的疾病部位。在这位 78 岁的疑似前列腺癌复发的男性中,PSMA PET/CT 显示脑部有放射性示踪剂摄取的焦点,这通常会引起对转移的怀疑,但在最近的中风情况下这是一个假阳性。已有报道称,PSMA 摄取增加与亚急性梗死、原发性和继发性脑肿瘤有关。在这些患者中,仔细的病史和与既往影像学检查的比较对于避免假阳性诊断至关重要。